Brian Andrew Van Tine

Whole-genome analysis informs breast cancer response to aromatase inhibition

Matthew J. Ellis, Li Ding, Dong Shen et al. · Nature · 2012 · 1K citations · Full text

Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial

George D. Demetri, Margaret von Mehren, Robin L. Jones et al. · Journal of Clinical Oncology · 2015 · 809 citations · Full text

Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials

Sandra P. D’Angelo, Michelle R. Mahoney, Brian Andrew Van Tine et al. · The Lancet Oncology · 2018 · 716 citations · Full text

Oncology, Ipilimumab Treatment, Clinical Trials +8

Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial

Sandra P. D’Angelo, Dejka M. Araujo, Albiruni R. Abdul Razak et al. · The Lancet · 2024 · 215 citations · Full text

Afamitresgene Autoleucel, Advanced Synovial Sarcoma, Medicine +3

Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness

Yize Li, T. Mamie Lih, Saravana M. Dhanasekaran et al. · Cancer Cell · 2022 · 183 citations · Full text